Ron Squarer Adc Therapeutics Sa (ADCT) insider trading activity

ADCT Quotes by TradingView

Ron Squarer is Director of ADC Therapeutics SA. Currently has a direct ownership of 93,627 shares of ADCT, which is worth approximately $252,792. The most recent transaction as insider was on Jun 13, 2025, when has been sold 15,184 shares (Common Shares) at a price of $3.58 per share, resulting in proceeds of $54,358. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 93.6K
16.07% 3M change
16.07% 12M change
Total Value Held $252,792

Ron Squarer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 13 2025
SELL
Payment of exercise price or tax liability
$54,358 $3.58 p/Share
15,184 Reduced 13.95%
93,627 Common Shares
Jun 03 2025
BUY
Grant, award, or other acquisition
-
40,000 Added 26.88%
108,811 Common Shares
Jun 17 2024
SELL
Open market or private sale
$20,215 $2.89 p/Share
6,995 Reduced 7.98%
80,663 Common Shares
Jun 13 2024
BUY
Grant, award, or other acquisition
-
40,000 Added 31.33%
87,658 Common Shares

Also insider at

DCPH
Deciphera Pharmaceuticals, Inc. Healthcare
TVTX
Travere Therapeutics, Inc. Healthcare
RS

Ron Squarer

Director
San Diego, CA

Track Institutional and Insider Activities on ADCT

Follow ADC Therapeutics SA and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ADCT shares.

Notify only if

Insider Trading

Get notified when an Adc Therapeutics Sa insider buys or sells ADCT shares.

Notify only if

News

Receive news related to ADC Therapeutics SA

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ADCT